4
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1789 |
Obeticholic Acid
奥贝胆酸,INT-747,6-Ethylchenodeoxycholic acid,6-ECDCA |
FXR; Autophagy | Autophagy; Metabolism |
Obeticholic Acid (6-ECDCA) 是一种选择性的,有口服活性的 FXR 激动剂,EC50为 99 nM。它可诱导细胞自噬,具有抗胆碱和抗炎作用。 | |||
T11428 |
Glyco-Obeticholic acid
|
FXR | Metabolism |
Glyco-obeticholic acid 是一种牛磺酸的特性代谢物。Obeticholic Acid 是口服具有活性的法尼样 X 受体激动剂。 | |||
T83858 |
Tauro-Obeticholic Acid sodium
Tauro-6-Ethylchenodeoxycholic Acid,Tauro-6-Ethyl-CDCA,Obeticholic Acid Taurine Conjugate,Tauro-OCA,T-ECDCA |
||
陶氏奥贝胆酸是奥贝胆酸的活性代谢物,属于法尼索德X受体(FXR)激动剂并且是熊脱氧胆酸的半合成衍生物。陶氏奥贝胆酸通过在肝脏中与牛磺酸结合形成,但可以通过肠道微生物被再次转换回奥贝胆酸。 | |||
T40296 |
MCA17-1
MCA17-1 |
||
MCA17-1 exhibits superior bioactivity compared to the positive control, obeticholic acid (OCA), in the treatment of liver fibrosis. |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T13092 |
Tauro-Obeticholic acid
|
FXR | Metabolism |
Tauro-Obeticholic acid 是一种牛磺酸的特性代谢物。Obeticholic Acid 是口服具有活性的法尼样 X 受体激动剂。 |